Related Experiment Video
Updated: Aug 15, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Regulation of the cyclin-dependent kinase inhibitor p57Kip2 expression by p63
Chiara Beretta1, Anna Chiarelli, Barbara Testoni
1Department of Biomolecular and Biotechnological Sciences, University of Milan, Milan, Italy.
Abstract:
The cyclin-dependent kinase (CDK) inhibitor p57Kip2 is a negative regulator of cell proliferation, binding to a variety of cyclin-CDK complexes and inhibiting their kinase activities. The p57Kip2 gene was recognized as a target gene for p73beta, one member of the p53 family. In spite of this, the phenotypes of p73 and p57Kip2 knockout mice do not resemble each other while there is a phenotypic overlap between the p57Kip2 null mice, the p63 null mice and patients affected by p63 associated syndromes, suggesting that p57Kip2 could be indeed a downstream target of p63. By ChIP we determined that in the HaCaT cell line the DeltaNp63alpha protein is associated to three different regions of the p57Kip2 gene. DeltaNp63 can activate both the endogenous p57Kip2 gene and a reporter vector containing a -2191 promoter fragment of the p57Kip2 gene. Natural p63 mutants, associated to the AEC syndrome, show a partial or complete lack of transactivation potential of the p57Kip2 promoter, while three other natural p63 mutants, associated to the EEC, LMS and SHFM-4 syndromes, were less affected. These data suggests that p63 play an important role in the regulation of p57Kip2 expression and that this regulation is subverted in AEC p63 mutants.
Insights
The p63 protein regulates cell proliferation by controlling the p57Kip2 gene. Certain p63 mutations disrupt this regulation, impacting human development and disease.
Area of Science:
- Molecular Biology
- Genetics
- Developmental Biology
Background:
- p57Kip2 is a cyclin-dependent kinase (CDK) inhibitor that negatively regulates cell proliferation.
- p57Kip2 was previously identified as a target gene of p73beta, a member of the p53 family.
- Phenotypic similarities between p57Kip2 null mice and p63 null mice suggest p57Kip2 may be a downstream target of p63.
Purpose of the Study:
- To investigate the role of p63 in regulating p57Kip2 gene expression.
- To determine if p63 directly binds to and activates the p57Kip2 gene promoter.
- To examine the impact of natural p63 mutants on p57Kip2 promoter activity.
Main Methods:
- Chromatin immunoprecipitation (ChIP) to identify p63 binding sites on the p57Kip2 gene.
- Reporter gene assays using a p57Kip2 promoter fragment to assess transactivation by p63.
- Analysis of p63 mutants associated with human syndromes (AEC, EEC, LMS, SHFM-4).
Main Results:
- DeltaNp63alpha protein directly associates with three regions of the p57Kip2 gene in HaCaT cells.
- DeltaNp63alpha activates both the endogenous p57Kip2 gene and a reporter construct containing the p57Kip2 promoter.
- p63 mutants linked to AEC syndrome exhibit significantly reduced or abolished transactivation of the p57Kip2 promoter, while other mutants show less impairment.
Conclusions:
- p63 plays a crucial role in regulating p57Kip2 expression.
- The regulatory relationship between p63 and p57Kip2 is disrupted in p63 mutants associated with AEC syndrome.
- These findings highlight the importance of p63-mediated p57Kip2 regulation in development and disease.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
DNA Damage Can Stall the Cell Cycle
